Skip to content

Preoperative risk stratification of patients with Aortic Stenosis

New risk stratification based on Cardiac structural repercussion in severe Aortic Stenosis and its impact on prognosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-7k48gfd
Enrollment
Unknown
Registered
2023-12-11
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis

Interventions

Group of 1200 patients diagnosed with severe Aortic Stenosis from the Instituto do Coração, Hospital das Clínicas, University of São Paulo, who underwent Aortic Valve Replacement Surgery between the p
V03.175.500

Sponsors

Hospital das Clínicas da Faculdade de Medicina da USP
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina da USP
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Severe Aortic Stenosis undergoing valve replacement surgery; age over 18 years; male and female genders

Exclusion criteria

Exclusion criteria: Severe aortic insufficiency; severe primary valvular heart disease; heart failure of non-valvular etiology; primary cardiomyopathies; severe obstructive pulmonary disease; endocarditis; three-vessel coronary disease; main stem lesion; previous cardiac surgery;active endocarditis

Design outcomes

Primary

MeasureTime frame
Test whether the new stratification predicts the primary composite outcome: all-cause mortality and hospital readmission at 24 months of follow-up after conventional aortic valve replacement surgery in patients with severe aortic stenosis.

Secondary

MeasureTime frame
Investigate whether there are other predictive factors for the composite outcome of all-cause mortality and in-hospital readmission during the same follow-up period.;Investigate the prevalence of isolated outcomes (death from all causes and hospital readmission) within the same follow-up period.;Test whether the new stratification predicts the secondary outcome of mortality from cardiovascular causes in the same follow-up period.

Countries

Brazil

Contacts

Public ContactCristhian Romero

Instituto do Coração, Universidade de São Paulo, Brasil

cristhian.espinoza@usp.br+5511993109363

Outcome results

None listed

Source: REBEC (via WHO ICTRP)